Group One Trading’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Group One Trading’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-25,900	Closed	-$2.53M	–	5551
2015 Q1	$2.53M	Buy	+25,900	New	+$2.74M	0.04%	528
2014 Q4	–	Sell	-5,500	Closed	-$378K	–	5735
2014 Q3	$378K	Sell	5,500 -5,000	-48%	-$358K	0.01%	1826
2014 Q2	$1.1M	Sell	10,500 -3,700	-26%	-$315K	0.02%	1068
2014 Q1	$1.18M	Buy	14,200 +12,400	+689%	+$1.15M	0.02%	966
2013 Q4	$117K	Buy	+1,800	New	+$107K	﹤0.01%	2895

Group One Trading's GEVA Position: Q2 2015 in Review

Group One Trading sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,677 shares — an estimated $359K sold.

Group One Trading first reported a position in GEVA in Q3 2013 and held it in 6 quarters. The position peaked at $1.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Group One Trading reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Group One Trading sold 3,677 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $359K.
Group One Trading first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 6 quarters.
Group One Trading's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.2M in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.